finding the patents only cover parts of an inhaler device and "do not claim or even mention" ProAir HFA's active ingredient. The Federal Circuit panel upheld the decision on Friday. "To list a ...
COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...
End-stage COPD is marked by severe shortness of breath, even when at rest. At this stage, medications typically don’t work as well as they may have in the past. Everyday tasks will leave you ...
A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...
Prescription and OTC weight loss medications are available, but only one nonprescription medication has Food and Drug Administration (FDA) approval. This article discusses what weight loss ...
Up to now, doctors have typically needed two CT scans to diagnose and judge COPD -- one when a person has fully inhaled, and one when a person has exhaled. “Our study shows that COPD diagnosis and ...
“Afrezza is a rapid-acting insulin delivered through an inhaler as compared to current insulins which are given as injections. Taken at the beginning of a meal, Afrezza dissolves rapidly upon ...
This could be a hard pill to swallow. Now, a board-certified anesthesiologist in Los Angeles is revealing five daily medications that may also increase your likelihood of developing dementia ...